Hope on the horizon: how pegbelfermin offers a glimmer of hope for NASH sufferers?
| Autor: | Sawairah Mukhtiar, Nisha Babar, Fatima Rehan |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Journal of the Pakistan Medical Association, Vol 73, Iss 12 (2023) |
| Druh dokumentu: | article |
| ISSN: | 0030-9982 |
| DOI: | 10.47391/JPMA.9769 |
| Popis: | Madam, Non-alcoholic steatohepatitis (NASH), is described as having hepatic steatosis of >5%, inflammation, and hepatocyte damage (such as ballooning), including or excluding fibrosis¹. NASH falls under a group of liver diseases termed Non-alcoholic Fatty Liver Disease (NAFLD) varying from benign steatosis to inflammatory NASH and hepatic fibrosis. ---Continue |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|